Monte Rosa Therapeutics, Inc.
GLUE
$4.59
-$0.23-4.77%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.83% | 69.04% | 60.12% | 35.70% | 29.12% |
| Total Receivables | -75.92% | 134.28% | -65.74% | 102.38% | 752.86% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.15% | -13.44% | 55.37% | 103.53% | 50.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.76% | 66.94% | 59.79% | 37.34% | 33.54% |
|
|
|||||
| Total Current Assets | 7.76% | 66.94% | 59.79% | 37.34% | 33.54% |
| Net Property, Plant & Equipment | -10.50% | -10.98% | -10.06% | -8.69% | -6.93% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.31% | 1.29% | 0.93% | 5.74% | 5.33% |
| Total Assets | 4.50% | 47.41% | 44.44% | 24.98% | 23.51% |
|
|
|||||
| Total Accounts Payable | -13.78% | -4.96% | 54.37% | -27.67% | 21.95% |
| Total Accrued Expenses | 13.39% | 38.73% | 19.35% | 21.87% | 24.83% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.95% | 15.55% | 17.46% | 26.55% | 30.15% |
| Total Finance Division Other Current Liabilities | -7.75% | 63.94% | 523.22% | 595.36% | 779.32% |
| Total Other Current Liabilities | -7.75% | 63.94% | 523.22% | 595.36% | 779.32% |
| Total Current Liabilities | -1.17% | 43.40% | 236.85% | 84.18% | 121.85% |
|
|
|||||
| Total Current Liabilities | -1.17% | 43.40% | 236.85% | 84.18% | 121.85% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.41% | -9.17% | -9.04% | -7.96% | -7.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -65.16% | -33.04% | -43.35% | 1,822.23% | 2,305.98% |
| Total Liabilities | -23.39% | 3.34% | 73.32% | 62.21% | 83.87% |
|
|
|||||
| Common Stock & APIC | 3.04% | 21.18% | 21.36% | 27.22% | 27.77% |
| Retained Earnings | 5.64% | 1.55% | -19.87% | -35.89% | -43.80% |
| Treasury Stock & Other | -26.33% | -23.62% | -23.20% | -59.59% | -62.80% |
| Total Common Equity | 19.32% | 80.41% | 24.37% | 11.34% | 5.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.32% | 80.41% | 24.37% | 11.34% | 5.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.32% | 80.41% | 24.37% | 11.34% | 5.16% |
|
|
|||||